6172
S. Shimizu et al. / Tetrahedron 57 (2001) 6169±6173
(EI, 70 eV) using GC±MS coupling. IR spectra were
recorded on a Bio-Rad FTS-60A spectrometer. Preparative
gel-permeation chromatography (GPC) was done with a JAI
model 908 liquid chromatograph with a couple of JAIGEL-
1H and 2H columns.
3.3.5. b-(4-Methoxyphenyl)-a-pheylacrylonitrile (6c).15a
1H NMR (400 MHz, CDCl3) d 7.90±7.87 (m, 2H), 7.66±
7.64 (m, 2H), 7.46±7.36 (m, 4H), 6.99±6.96 (m, 2H), 3.86
(s, 3H); 13C NMR (100 MHz, CDCl3) d 161.39, 141.85,
134.80, 131.18, 128.98, 128.72, 126.48, 125.74, 118.54,
114.36, 108.58, 55.40; IR (KBr) 3016, 2844, 2210, 1603,
1595, 1512, 1255, 1180, 1027, 832, 694 cm21; MS (EI) m/z
235 (M1, 100), 204 (8), 190 (10), 165 (16).
3.2. Materials
The water-soluble calix[n]arenes 1n´nH2O (n4, 6 and 8)
were prepared by following literature methods17 and identi-
®ed by IR and NMR spectroscopy as well as elemental
analysis. Cetyltrimethylammonium bromide and b-cyclo-
dextrin were purchased from Tokyo Kasei Kogyo, and
used without further puri®cation.
3.3.6. b-Naphthylmethyl-a-pheylacrylonitrile (6d). 1H
NMR (400 MHz, CDCl3) d 8.27 (s, 1H), 8.08 (d, 1H,
J7.2 Hz), 7.98±7.89 (m, 3H), 7.78±7.76 (m, 2H), 7.59±
7.42 (m, 6H); 13C NMR (100 MHz, CDCl3) d 140.22,
134.40, 133.70, 131.71, 131.27, 130.75, 129.48, 129.20,
129.02, 127.07, 126.99, 126.45, 126.30, 125.57, 123.43,
117.63, 115.57; IR (KBr) 3041, 2219, 1448, 890, 781,
758, 685 cm21; MS (EI) m/z 255 (M1, 100), 254 (66), 240
(18), 228 (15), 177 (13), 127 (12), 113 (13).
3.3. Typical procedure for the aldol-type condensation
and Michael addition
To a 10 mL three-necked ¯ask containing 1n´nH2O
(1 mol%) was added an aqueous 5N NaOH solution
(3 mL). An activated methyl or methylene compound and
aldehyde or enone were then introduced. The reaction
mixture was stirred with a magnetic stirring bar at
800 rpm for 0.2±2 h at rt2608C (depending on the
substrates). After addition of water (5 mL), the resulting
mixture was extracted with chloroform (10 mL£3). The
combined extracts were dried with anhydrous Na2SO4 and
evaporated. The products were puri®ed by preparative GPC
and the isolated yields were determined.
3.3.7. 1,2,3-Triphenyl-1,3-propanedicarbonitrile (7a).
1
(Diastereomer ratio: A/B/C62/32/6) H NMR (400 MHz,
CDCl3) d 7.36±6.64 (m, 15H), 4.82 (d, 0.32H, J5.2 Hz,
for B), 4.45 (d, 0.32H, J10.6 Hz, for B), 4.41 (d, 0.12H,
J7.7 Hz, for C), 4.13 (d, 1.24H, J8.1 Hz, for A), 3.86 (t,
0.06H, J7.7 Hz, for C), 3.45 (dd, 0.32H, J10.6, 5.2 Hz,
for B), 3.37 (t, 0.62H, J8.1 Hz, for A); IR (KBr) 3065,
3033, 2245, 1495, 1455, 757, 747, 701 cm21; MS (EI) m/z
322 (M1), 206 (100), 179.
3.3.8.
2-(4-Chlorophenyl)-1,3-diphenyl-1,3-propane-
3.3.1. E-1-Benzylidene-1H-indene (4a).6 1H NMR (400
MHz, CDCl3) d 7.71±6.98 (m, 12H); 13C NMR (100
MHz, CDCl3) d 142.08, 140.09, 137.44, 136.93, 134.56,
130.24, 128.72, 128.69, 128.34, 127.56, 126.11, 125.16,
120.96, 119.15; IR (KBr) 3062, 1443, 795, 762, 694,
505 cm21; MS (EI) m/z 204 (M1, 100), 203 (95), 202
(62), 101 (27), 89 (10), 76 (6).
dicarbonitrile (7b). (Diastereomer ratio: A/B/C64/27/9)
1H NMR (400 MHz, CDCl3) d 7.38±6.55 (m, 14H), 4.82 (d,
0.27H, J5.0 Hz, for B), 4.40 (d, 0.27H, J10.7 Hz, for B),
4.37 (d, 0.18H, J7.7 Hz, for C), 4.11 (d, 1.28H, J8.1 Hz,
for A), 3.86 (t, 0.09H, J7.7 Hz, for C), 3.45 (dd, 0.27H,
J10.7, 5.0 Hz, for B), 3.37 (t, 0.64H, J8.1 Hz, for A); IR
(KBr) 3066, 3035, 2244, 1495, 1456, 1095, 1015, 755, 733,
700 cm21; MS (EI) m/z 358 ([M12]1), 356 (M1), 240
(100), 213, 205, 178, 117.
3.3.2. Benylideneacetophenone (4b).5b 1H NMR (400
MHz, CDCl3) d 8.04±7.39 (m, 12H); 13C NMR (100
MHz, CDCl3) d 190.58, 144.86, 138.22, 134.89, 132.79,
130.56, 128.97, 128.64, 128.51, 128.46, 122.10; IR (KBr)
3081, 2917, 1664, 1605, 1576, 1449, 1336, 1215, 1016, 747,
689 cm21; MS (EI) m/z 208 (M1, 100), 207 (97), 179 (16),
131 (41), 105 (21), 103 (22), 77 (58), 51 (16).
3.3.9.
2-(4-Methoxyphenyl)-1,3-diphenyl-1,3-propane-
dicarbonitrile (7c). (Diastereomer ratio: A/B/C64/28/8)
1H NMR (400 MHz, CDCl3) d 7.37±6.53 (m, 14H), 4.78 (d,
0.28H, J5.1 Hz, for B), 4.39 (d, 0.28H, J10.5 Hz, for B),
4.36 (d, 0.16H, J7.7 Hz, for C), 4.09 (d, 1.28H, J8.0 Hz,
for A), 3.85±3.81 (t, 0.08H, for C), 3.78 (s, 1.92H, for A), 3.70
(s, 0.24H, for C), 3.69 (s, 0.84H, for B), 3.41 (dd, 0.28H,
J10.5, 5.1 Hz, for B), 3.33 (t, 0.64H, J8.0 Hz, for A); IR
(KBr) 3002, 2965, 2839, 2241, 1516, 1455, 1254, 1181, 1032,
760, 743, 699 cm21; MS (EI) m/z 352 (M1), 236 (100).
3.3.3. a-Phenylcinnamonitrile (6a).15b 1H NMR (400
MHz, CDCl3) d 7.90±7.88 (m, 2H), 7.69±7.67 (m, 2H),
7.54 (s, 1H), 7.50±7.38 (m, 6H); 13C NMR (100 MHz,
CDCl3) d 142.24, 134.43, 133.69, 130.52, 129.25, 129.19,
129.05, 128.94, 125.97, 117.99, 111.64; IR (KBr) 3032,
2019, 1447, 938, 908, 761, 744, 692, 518 cm21; MS (EI)
m/z 205 (M1, 100), 204 (71), 190 (31), 177 (16), 102 (10),
89 (19).
3.3.10. 2-(1-Naphthyl)-1,3-diphenyl-1,3-propanedicarbo-
nitrile (7d). This compound has not been isolated because
of its trace amount. MS (EI) m/z 372 (M1), 256, 178 (100).
3.3.4. b-(4-Chlorophenyl)-a-pheylacrylonitrile (6b).15a
1H NMR (400 MHz, CDCl3) d 7.84±7.82 (m, 2H), 7.68±
7.66 (m, 2H), 7.48±7.41 (m, 6H); 13C NMR (100 MHz,
CDCl3) d 140.58, 136.39, 134.09, 132.13, 130.45, 129.41,
129.20, 129.10, 125.96, 117.73, 112.22; IR (KBr) 3057,
3036, 2220, 1589, 1493, 1448, 1092, 829, 762, 691,
522 cm21; MS (EI) m/z 241 ([M12]1, 29), 239 (M1, 89),
204 (100), 177 (20), 101 (13), 88 (26).
3.3.11. 1,2-Diphenyl-1,3-propanedicarbonitrile (9a). (Dia-
stereomer ratio: A/B60/40) 1H NMR (400 MHz, CDCl3) d
7.37±7.17 (m, 10H), 4.29 (d, 0.6H, J8.0 Hz, for A), 4.17
(d, 0.4H, J6.8 Hz, for B), 3.50±3.38 (m, 1H), 2.98 (dd,
0.4H, J16.8, 9.6 Hz, for B), 2.88±2.78 (m, 1H), 2.98 (dd,
0.6H, J16.9, 7.3 Hz, for A); IR (KBr) 3065, 3035, 2924,
2245, 1601, 1494, 1456, 1422, 760, 701 cm21; MS (EI) m/z
246 (M1), 130 (100), 117, 103, 77.